FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)

View source ↗

Summary

The FDA approved a supplemental application for AUVI-Q (epinephrine auto-injector) from Kaleo, Inc., for the emergency treatment of anaphylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis

Drugs mentioned

• AUVI-Q (Epinephrine)

Snippet

SUPPL AP for AUVI-Q (EPINEPHRINE)